Paragangliomas 4
What's New
Last Posted: Jan 15, 2025
- Clinical exome next?generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosis.
Beatrice Melli, et al. Experimental and therapeutic medicine 2025 0 (2) 34 - Long-term persistence of glycemic dysregulation in patients with a history of pheochromocytoma/paraganglioma.
Alessa Fischer, et al. The Journal of clinical endocrinology and metabolism 2025 0 - Pheochromocytoma in von Hippel-Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma.
Tianyi Li, et al. Clinical endocrinology 2024 0 - Insights into the genetic landscape of pheochromocytomas and paragangliomas in a Brazilian cohort.
Gustavo F C Fagundes, et al. European journal of endocrinology 2024 0 - Genetic landscape of Romanian PPGLs.
Sofia-Maria Lider-Burciulescu, et al. Journal of cellular and molecular medicine 2024 0 (23) e70204 - Algorithm of genetic diagnosis for patients with head and neck paraganglioma-update.
Katarzyna Radomska, et al. Frontiers in neurology 2024 0 1437027 - Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective.
Felipe Freitas-Castro, et al. Best practice & research. Clinical endocrinology & metabolism 2024 0 101922 - Genetic background and intraoperative haemodynamic instability in patients with pheochromocytoma and paraganglioma: a multicenter retrospective study.
Minghao Li, et al. International journal of surgery (London, England) 2024 0 - Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review.
Kwan Hoon Jo, et al. Annals of laboratory medicine 2024 0 - Succinate dehydrogenase mutations in head and neck paragangliomas: A systematic review and meta-analysis of individual patients' data.
Elizabeth S Koh, et al. Head & neck 2024 0 - Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.
Young-Gyu Park, et al. Clinical genitourinary cancer 2024 0 - Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
Marta Araujo-Castro, et al. Frontiers in endocrinology 2023 0 1279828 - The Natural History of Observed SDHx-Related Head and Neck Paragangliomas Using Three-Dimensional Volumetric Tumor Analysis.
Evan L Tooker, et al. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2023 0 - Genotype-phenotype associations in paragangliomas of the temporal bone in a multi-ethnic cohort.
Simon I Angeli, et al. Acta oto-laryngologica 2023 0 1-7 - Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients with Paraganglioma.
Fagundes Gustavo F C, et al. The Journal of clinical endocrinology and metabolism 2023 0 - SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas.
Manotas María Carolina, et al. Frontiers in genetics 2023 0 999329 - Serum succinate/fumarate ratio in paraganglioma/pheochromocytoma patients attending an endocrine oncogenetic unit.
Bancel Léo-Paul, et al. The Journal of clinical endocrinology and metabolism 2023 0 - The SDHD:p.H102R Variant Is Frequent in Russian Patients with Head and Neck Paragangliomas and Associated with Loss of 11p15.5 Region and Hypermethylation of H19-DMR.
Snezhkina Anastasiya, et al. International journal of molecular sciences 2023 0 (1) - Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing.
Chew Winston Hong Wern, et al. Molecular genetics & genomic medicine 2017 0 (5) 602-607 - DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas.
Mannelli Massimo, et al. European journal of endocrinology 2017 0 (1) R11-R17
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: